Former BARDA Director Rick Bright said in a whistleblower complaint that he worried about widespread use of chloroquine as a coronavirus treatment, given its limited efficacy data and adverse event profile. • Source: Shutterstock
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
